about
Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumorsMonocyte Trafficking, Engraftment, and Delivery of Nanoparticles and an Exogenous Gene into the Acutely Inflamed Brain Tissue - Evaluations on Monocyte-Based Delivery System for the Central Nervous SystemTargeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy.Evaluation of adenovirus capsid labeling versus transgene expressionTargeting of mesenchymal stem cells to ovarian tumors via an artificial receptor.Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs.The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targetingCurrent progress in the development of a prophylactic vaccine for HIV-1.Development of individualized anti-metastasis strategies by engineering nanomedicinesA prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer.A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropismTumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds.Non-hematopoietic stem cells as factories for in vivo therapeutic protein production.Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.The promise of stem cell-based therapeutics in ophthalmology.Preparation of cationized polysaccharides as gene transfection carrier for bone marrow-derived mesenchymal stem cells.Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative.Factory neovessels: engineered human blood vessels secreting therapeutic proteins as a new drug delivery system.Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases.Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies.Could bioengineered exosome-mimetic nanovesicles be an efficient strategy for the delivery of chemotherapeutics?A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy
P2860
Q26741260-C4FBCE89-6CC1-406A-894A-29CDD7C5EB99Q27312829-DE391E02-3CC5-4D73-8020-185DE8E35BAEQ30411312-FB07680F-A6F0-4741-B75E-F90986BDC798Q33553585-5593DFD7-AEF3-4CCC-9D68-2AD6DD68B4F0Q33669272-77395644-7CE1-4A2C-8C49-B71AD0B0E18FQ33907262-015E5E07-3A0F-4EC4-8C63-7C5718838D61Q33931602-3C5B03BE-D1AC-4763-B867-CF01952E7BAEQ33983876-F5CFFB0B-763D-474A-A6A1-F40F8BE5C472Q34502108-CAB17359-DA91-406D-8B87-DE5580F69104Q35967474-3E7BC609-FA0E-4F8B-9B1D-167AF8E9CE1AQ36776738-AB9FBE86-E62E-41A8-A961-881E7FEA111BQ37150738-43085A6F-1A09-4E40-B326-0359403525ADQ37312523-C0CE41EB-F6DE-4264-974C-DF14EC8151A4Q37874445-574A026A-3584-4342-8A24-EB4A77B602FAQ38865261-C8EE596A-4ED6-433A-A1EA-871AA39A51DBQ39236145-4619B93A-7F97-4A6A-B494-6A559E968732Q43186978-EE4CBD9C-4D86-48C1-AB22-2D1A4D9BBDDDQ43808328-2D5161C3-6EC9-4552-90D6-ECF70B85E6F4Q45857985-EB3BB0B7-B57B-4558-BAF1-35AC9A4E8722Q46277755-2C7C7C7B-F6AC-44F3-8241-9749B9763D8FQ48117495-1EB77B00-CD56-44CA-8CB6-EE5CA94BD5ABQ51752461-DD5EB78E-5E7F-45FE-BAF4-15B7021D58E9Q57491566-C00C722A-74CD-4C7E-922E-B093728E4619
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell vehicle targeting strategies.
@en
Cell vehicle targeting strategies.
@nl
type
label
Cell vehicle targeting strategies.
@en
Cell vehicle targeting strategies.
@nl
prefLabel
Cell vehicle targeting strategies.
@en
Cell vehicle targeting strategies.
@nl
P2860
P356
P1433
P1476
Cell vehicle targeting strategies.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2008.38
P577
2008-03-27T00:00:00Z